Janssen Pharmaceutica has announced results from two Phase III clinical studies of esketamine nasal spray, a drug closely related to ketamine, in patients with treatment-resistant depression. Presented at the American Psychiatric Association annual meeting, the […]
Even mild traumatic brain injury (TBI) without loss of consciousness (LOC) is associated with increased risk of dementia among veterans, according to a study published online May 7 in JAMA Neurology. Deborah E. Barnes, Ph.D., […]
Hypertensive patients may lower their stroke risk with folic acid supplements, according to a study published in the May 15 issue of the Journal of the American College of Cardiology. Xiangyi Kong, M.D., from Peking […]
MDMA-assisted psychotherapy could be an effective treatment option for post-traumatic stress disorder (PTSD) according to a recent study. Published in the peer-reviewed journal The Lancet Psychiatry, the trial assessed whether MDMA-assisted psychotherapy could be beneficial […]
monARC Bionetworks has started an integration with the drug development platform of Roivant Sciences, a biopharmaceutical company focused on reducing the time and cost of the drug development process. monARC’s multi-disciplinary team of drug developers […]